Sci Show: A peptide-based vaccine candidate, called CoVac-1, is shown to induce immunity against SARS-CoV-2 in a phase I clinical trial reported in Nature. The vaccine candidate induces T cell immunity and could be helpful for people with immunodeficiencies.

Saturday, November 27, 2021

A peptide-based vaccine candidate, called CoVac-1, is shown to induce immunity against SARS-CoV-2 in a phase I clinical trial reported in Nature. The vaccine candidate induces T cell immunity and could be helpful for people with immunodeficiencies.

https://ift.tt/3l3o99m via /r/science https://ift.tt/3E1ifwH

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)